球囊主动脉瓣成形术市场基于(主要地区、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00039182
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 160
Buy Now

Balloon Aortic Valvuloplasty Market Size, Growth, Share by 2031

Buy Now

球囊主动脉瓣膜成形术市场规模预计将从 2023 年的 1.2508 亿美元增至 2031 年的 1.9027 亿美元。预计 2023 年至 2031 年市场复合年增长率为 5.4%。有助于改善经导管主动脉瓣植入术 (TAVI) 的新兴研发策略可能仍然是市场的主要趋势。

球囊主动脉瓣膜成形术市场分析

推动球囊瓣膜成形术设备市场增长的因素包括人口迅速老龄化和主动脉瓣狭窄患病率的增加。主动脉瓣狭窄已成为最常见的需要手术治疗的瓣膜疾病。主动脉瓣球囊成形术 (BAV) 除了在 TAVI 手术中发挥作用外,还可以作为瓣膜置换术的桥接疗法,对多种主动脉瓣狭窄患者有帮助。球囊瓣膜成形术设备医疗报销的增加、微创手术的日益普及以及更好的医疗基础设施是促进市场增长的其他因素。微创方法通常涉及较小的切口,使用专门的仪器和技术来进入心脏,这可以缩短住院时间并减少疤痕。此外,医疗保健组织正在投资培训其医疗团队并获取必要的设备,以满足对微创 BAV 和 TAVI 手术不断增长的需求,从而为患者提供增强的治疗选择和更好的整体医疗保健体验。因此,球囊主动脉瓣膜成形术市场出现显着增长。

球囊主动脉瓣膜成形术市场概述

超过一半患有严重心脏瓣膜疾病的患者在出现症状后两年内死亡。全球心脏中心在 Heart Valve Voice Canada 2020 上发表的调查结果表明,60 岁及以上的加拿大人中只有 3% 意识到主动脉瓣狭窄。因此,提高对心脏瓣膜疾病的认识并及早发现对于患者、依赖患者的人以及当地社区至关重要。加拿大心血管学会成立了心脏瓣膜疾病战略工作组,以解决加拿大心脏瓣膜疾病护理方面的差距。 2021 年 1 月,美敦力 (Medtronic) 收到了加拿大卫生部对 Evolut TAVI 系统的扩大适应症。美敦力 (Medtronic) 的 TAVI 平台是唯一获得双叶主动脉瓣(中危或高危患者)许可的系统。 Evolut 在该国适用于所有风险类别的严重主动脉瓣狭窄患者。 2021 年 9 月,雅培 (Abbott) 获得美国食品和药物管理局 (FDA) 批准 Portico 与 FlexNav 经导管主动脉瓣置换术 (TAVR) 系统,用于治疗有症状、严重主动脉瓣狭窄且面临心脏直视手术高风险的患者。

定制研究以满足您的要求

我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

球囊主动脉瓣膜成形术市场:

Balloon Aortic Valvuloplasty Market: Strategic Insights

Balloon Aortic Valvuloplasty Market

  • CAGR (2023 - 2031)
    5.4%
  • Market Size 2023
    US$ 125.08 Million
  • Market Size 2031
    US$ 190.27 Million

Market Dynamics

GROWTH DRIVERS
  • 主动脉瓣狭窄患病率上升
FUTURE TRENDS
  • 微创手术需求不断增长
OPPORTUNITIES
  • 主动脉瓣置换技术的进展

Key Players

  • B Braun SE
  • TT Medical Inc.
  • Balton
  • Becton Dickinson and Co
  • Edwards Lifesciences Corp
  • Balt
  • Venus MedTech HangZhou Inc.
  • NuMED
  • simeks
  • OSYPKA

Regional Overview

  • 北美(美国、加拿大、墨西哥)
  • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
  • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
  • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
  • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)

Market Segmentation

产品类型(非顺应性气球、半顺应性气球)

    球囊主动脉瓣膜成形术市场

    • 年均复合增长率(2023 - 2031)
      5.4%
    • 2023 年市场规模
      12508 万美元
    • 2031 年市场规模
      1.9027 亿美元

    市场动态

    增长动力
    • 主动脉瓣狭窄的患病率上升
    未来的趋势
    • 对微创手术的需求不断增长
    机会
    • 主动脉瓣置换技术的进展

    关键人物;主力;重要一员

    • B 布劳恩 SE
    • TT 医疗公司
    • 巴尔顿
    • 贝克顿迪金森公司
    • 爱德华兹生命科学公司
    • 巴尔特
    • 杭州启明医疗科技有限公司
    • 努梅德
    • 西梅克斯
    • 奥西普卡

    区域概况

    • 北美
    • 欧洲
    • 亚太
    • 南美洲和中美洲
    • 中东和非洲

    市场细分

    产品类别
    • 不合格的气球
    • 半顺应性气球
    • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

    球囊主动脉瓣膜成形术市场驱动因素和机遇

    对微创手术的需求不断增长有利于市场增长

    瓣膜置换手术中对微创技术的需求不断飙升,反映出医疗实践和患者偏好的重大转变。在微创主动脉瓣成形术中,心脏的主动脉瓣得到修复,如果需要,还可以通过 TAVI 手术进行更换。微创技术的驱动力是减少手术的侵入性、最大限度地减少相关风险并促进更快的恢复时间。

    包括心脏病学在内的所有医学分支都见证了对微创手术的需求不断增加,因为微创手术比传统的心脏直视手术具有多种优势。与心脏直视手术相比,接受微创手术的患者通常恢复时间较短。此外,与心脏直视手术相比,微创技术的并发症风险较低,疤痕也较少。由于医疗设备的进步,外科医生已经采用了这些技术,而手术技能的提高可以进一步促进广泛采用。由于 BAV 是一种微创技术,可用于治疗包括主动脉瓣狭窄在内的各种心脏问题,因此对微创手术的需求不断增加,推动了 BAV 设备的市场。

    主动脉瓣置换技术的进展

    与外科手术相比,心脏病患者接受经导管手术治疗后症状会在更短的时间内得到改善。由于技术的进步,TAVI 等微创手术技术使主动脉瓣狭窄的治疗变得现代化。此外,设计的改进导致了更坚固和生物相容性主动脉瓣置换术的开发,这提高了患者的治疗效果并降低了并发症的风险。以下是各公司在主动脉瓣球囊成形术和主动脉瓣置换装置方面取得的一些技术进步:

    • 2023 年 1 月,雅培的 Navitor TAVI 系统获得 FDA 批准,用于治疗严重主动脉瓣狭窄和不适合进行心脏直视手术的患者。 Navitor 是该公司广泛的经导管结构心脏产品组合中最新推出的产品;它为医生和患者提供针对一系列严重心脏病的侵入性较小的治疗替代方案。
    • 2020 年 9 月,波士顿科学公司在欧洲推出了 ACURATE neo2 主动脉瓣系统。下一代 TAVI 技术是一个具有多种功能的新平台,旨在提高原始 ACURATE neo 平台的临床性能,与上一代主动脉瓣系统相比,它对主动脉瓣狭窄患者的适应症得到了扩展。

    因此,技术进步为球囊主动脉瓣膜成形术市场的增长提供了利润丰厚的机会。

    球囊主动脉瓣成形术市场报告细分分析

    促成球囊主动脉瓣成形术市场分析的关键部分是产品类型。

    根据产品类型,球囊主动脉瓣膜成形术市场分为非顺应性球囊和半顺应性球囊。不合规气球细分市场在 2023 年占据了更大的市场份额,预计 2023 年至 2031 年市场复合年增长率将更高。

    按地区划分的球囊主动脉瓣膜成形术市场份额分析

    球囊主动脉瓣膜成形术市场报告的地理范围主要分为五个地区:北美、亚太地区、欧洲、中东和非洲、南美洲和中美洲。

    北美占据了很大的市场份额。该地区市场的增长归因于心脏瓣膜疾病患病率的上升、各个组织不断采取举措提高人们对心脏瓣膜疾病的认识以及治疗设备的进步。据经济合作与发展组织称,墨西哥心血管疾病的负担正在迅速增加。墨西哥正在通过提高认识计划来解决与成人和老年人群心脏病相关的危险因素。为了响应这些意识计划,经导管主动脉瓣置换手术已获得关注,并且通常被首选作为心脏直视瓣膜手术的替代方案。墨西哥城的心脏病专家使用最好的技术和技巧进行 TAVI。 CMQ 医院是巴亚尔塔港和里维埃拉纳亚里特 TAVI 手术的领导者。医院拥有多学科的介入心脏病学专业团队,保证为每位患者提供全面、个性化的护理。

    在加拿大,主动脉瓣狭窄最常见的原因是由于衰老导致的退行性瓣膜疾病,其次是先天性二尖瓣主动脉瓣疾病和风湿性心脏病。根据健康经济研究所2022年3月发布的《加拿大心脏瓣膜疾病》,主动脉瓣狭窄和二尖瓣关闭不全是两种最常见的心脏瓣膜疾病。据报道,全国约有2.5%的人口患有心脏瓣膜疾病,65岁以后这一比例显着增加,75岁及以上人群中这一比例达到13%。据估计,到2040年,加拿大将有150万65岁以上的人患有心脏瓣膜疾病。

    在加拿大,大量市场参与者提供 TAVI 产品。 Edwards Lifesciences、Boston Scientific Corporation、Medtronic Inc.、JenaValve Technology 和 Transcatheter Technologies GmbH 是市场上运营的几家制造商。这些制造商已获得加拿大政府的监管批准。 Edwards SAPIEN 和 Medtronic CoreValve 系统已在加拿大获得许可。

    球囊主动脉瓣成形术市场报告范围

    报告属性细节
    2023年市场规模12508万美元
    2031 年市场规模1.9027 亿美元
    全球复合年增长率(2023 - 2031)5.4%
    历史数据2021-2022
    预测期2024-2031
    涵盖的细分市场按产品类型
    • 不合格的气球
    • 半顺应性气球
    覆盖地区和国家北美
    • 我们
    • 加拿大
    • 墨西哥
    欧洲
    • 英国
    • 德国
    • 法国
    • 俄罗斯
    • 意大利
    • 欧洲其他地区
    亚太
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
    南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区
    中东和非洲
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
    市场领导者和主要公司简介
    • B 布劳恩 SE
    • TT 医疗公司
    • 巴尔顿
    • 贝克顿迪金森公司
    • 爱德华兹生命科学公司
    • 巴尔特
    • 杭州启明医疗科技有限公司
    • 努梅德
    • 西梅克斯
    • 奥西普卡
    • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

    球囊主动脉瓣膜成形术市场新闻和最新动态

    主动脉瓣球囊成形术市场是通过收集初级和二级研究后的定性和定量数据来评估的,其中包括重要的公司出版物、协会数据和数据库。下面列出了球囊主动脉瓣成形术市场的一些发展:

    • 雅培在印度推出了最新一代 TAVI 系统 Navitor,为该国面临高或极高手术风险的严重主动脉瓣狭窄患者提供微创设备。 Navitor 采用独特的织物袖带 (NaviSeal),可与心动周期配合,最大限度地减少或消除血液穿过瓣膜框架的回流,即瓣膜旁漏。 (来源:雅培,新闻稿,2022 年 12 月)
    • Keystone Heart, Ltd. 与 InterValve Medical Inc. 签订独家经销协议,在美国销售和营销其球囊主动脉瓣膜成形术产品组合。根据协议,Keystone Heart Ltd. 开始在美国市场销售 V8 和 TAV8 主动脉瓣膜成形球囊导管 (InterValve Medical)。 (来源:Keystone Heart, Ltd;新闻稿,2021 年 3 月)

    球囊主动脉瓣膜成形术市场报告范围和交付成果

    《球囊主动脉瓣膜成形术市场规模和预测(2021-2031)》报告对涵盖以下领域的市场进行了详细分析:

    • 球囊主动脉瓣成形术市场规模以及全球、区域和国家层面涵盖的所有主要细分市场的预测
    • 球囊主动脉瓣成形术市场趋势以及市场动态,例如驱动因素、限制因素和关键机遇
    • 详细的 PEST 和 SWOT 分析
    • 球囊主动脉瓣成形术市场分析,涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
    • 行业格局和竞争分析,包括市场集中度、热图分析、知名参与者以及球囊主动脉瓣膜成形术市场的最新发展
    • 详细的公司简介

    Balloon Aortic Valvuloplasty Market Report Scope

    Report Attribute Details
    Market size in US$ 125.08 Million
    Market Size by US$ 190.27 Million
    Global CAGR 5.4%
    Historical Data 2021-2022
    Forecast period 2024-2031
    Segments Covered By 产品类型(非顺应性气球、半顺应性气球)
    Regions and Countries Covered 北美(美国、加拿大、墨西哥)
    • 北美(美国、加拿大、墨西哥)
    欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
    • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
    亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
    • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
    南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
    • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
    中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
    • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
    Market leaders and key company profiles
  • B Braun SE
  • TT Medical Inc.
  • Balton
  • Becton Dickinson and Co
  • Edwards Lifesciences Corp
  • Balt
  • Venus MedTech HangZhou Inc.
  • NuMED
  • simeks
  • OSYPKA
  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What would be the estimated value of the balloon aortic valvuloplasty market by 2031?

    The estimated value of the balloon aortic valvuloplasty market can reach US$ 190.27 million by 2031.

    Which region dominated the balloon aortic valvuloplasty market in 2023?

    North America region dominated the balloon aortic valvuloplasty market in 2023.

    Which are the leading players operating in the balloon aortic valvuloplasty market?

    B Braun SE, TT Medical, Inc., Balton, Becton Dickinson and Co, Edwards Lifesciences Corp, Balt, Venus MedTech HangZhou Inc., NuMED, simeks, and OSYPKA are among the key market players in the balloon aortic valvuloplasty market.

    What is the expected CAGR of the balloon aortic valvuloplasty market?

    The global balloon aortic valvuloplasty market is estimated to register a CAGR of 5.4% during the forecast period 2023–2031.

    What are the driving factors impacting the balloon aortic valvuloplasty market?

    The rising prevalence of aortic valve stenosis and increasing demand for minimally invasive procedures are the most influential factors responsible for market growth.

    The List of Companies - Balloon Aortic Valvuloplasty Market

    1. B Braun SE
    2. TT Medical, Inc.
    3. Balton
    4. Becton Dickinson and Co
    5. Edwards Lifesciences Corp 
    6. Balt 
    7. Venus MedTech HangZhou Inc 
    8. NuMED
    9. simeks 
    10. OSYPKA

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Medical Device : READ MORE..